Grace Therapeutics, Inc.
GRCE · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,568 | -$12,853 | -$42,429 | -$9,819 |
| Dep. & Amort. | $7 | $11 | $124 | $0 |
| Deferred Tax | -$3,199 | -$1,832 | -$9,542 | -$648 |
| Stock-Based Comp. | $730 | $913 | $1,811 | $1,337 |
| Change in WC | $342 | -$1,280 | $181 | -$2,786 |
| Other Non-Cash | -$3,216 | $2,708 | $33,942 | -$5,318 |
| Operating Cash Flow | -$14,904 | -$12,333 | -$15,913 | -$17,234 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$22 | -$17 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$15 | -$6,554 | -$5,015 | -$34,929 |
| Inv. Sales/Matur. | $15 | $6,569 | $18,185 | $31,407 |
| Other Inv. Act. | $0 | $111 | $0 | $0 |
| Investing Cash Flow | $0 | $104 | $13,153 | -$3,522 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $14,999 | $7,500 | $304 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$967 | -$141 | $0 | $0 |
| Financing Cash Flow | $14,032 | $7,359 | $304 | $0 |
| Forex Effect | $0 | $0 | -$8 | $153 |
| Net Chg. in Cash | -$872 | -$4,870 | -$2,464 | -$20,603 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $23,005 | $27,875 | $30,339 | $50,942 |
| End Cash | $22,133 | $23,005 | $27,875 | $30,339 |
| Free Cash Flow | -$14,904 | -$12,355 | -$15,930 | -$17,234 |